Potassium trans-3-methoxy-1-propenyltrifluoroborate
Product Information
Molecular Formula
C4H7BF3KO
Molecular Weight
178.00
Description
Potassium trans-3-methoxy-1-propenyltrifluoroborate is a biomedical compound that manifests intrinsic potency in its therapeutic applications against an array of debilitating pathologies. Concentrating its pharmacological prowess on precisely targeted cellular anomalies associated with diverse disorders, this product serves as an indispensable active constituent in the formulation of ailment-specific medications.
Synonyms
potassium; trifluoro-[(E)-3-methoxyprop-1-enyl]boranuide; SCHEMBL15094217; 1025825-38-0
IUPAC Name
potassiumtrifluoro-[(E)-3-methoxyprop-1-enyl]boranuide
SMILES
[B-](C=CCOC)(F)(F)F.[K+]
InChI
InChI=1S/C4H7BF3O.K/c1-9-4-2-3-5(6,7)8;/h2-3H,4H2,1H3;/q-1;+1/b3-2+;
InChI Key
FTWBCMBVSLEMPY-SQQVDAMQSA-N
Melting Point
173-189 °C
Purity
95%
Safety Information
Hazards
H315-H319-H335
Precautionary Statement
P261-P305 + P351 + P338
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
178.0179110 g/mol
Monoisotopic Mass
178.0179110 g/mol
Topological Polar Surface Area
9.2Ų
Heavy Atom Count
10
Formal Charge
0
Complexity
103
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
1
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
2
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| AU-2013340896-A1 | Pressure process | 2012-10-31 |
| AU-2013340896-A2 | Pressure process | 2012-10-31 |
| AU-2013340896-B2 | Pressure process | 2012-10-31 |
| EP-2914563-A1 | Pressure process | 2012-10-31 |
| JP-2016500645-A | Printing method | 2012-10-31 |
| JP-6353455-B2 | Printing method | 2012-10-31 |
| KR-102104692-B1 | Printing method | 2012-10-31 |
| US-9908819-B1 | Printing method for production a ceramic green body | 2012-10-31 |
| WO-2014067990-A1 | Pressure process | 2012-10-31 |
| AU-2013207205-A1 | 4,4-disubstituted-1,4-dihydropyrimidines and the use thereof as medicaments for the treatment of Hepatitis B | 2012-01-06 |
